Allied Biotech Corporation (TPEX:1780)
Taiwan · Delayed Price · Currency is TWD 25.45
-0.65 (-2.49%)
Jan 22, 2026, 1:52 PM CST
Allied Biotech Market Cap
Allied Biotech has a market cap or net worth of 2.51 billion as of January 21, 2026. Its market cap has increased by 53.88% in one year.
Market Cap
2.51B
Enterprise Value
2.46B
Revenue
821.81M
Ranking
n/a
PE Ratio
26.62
Stock Price
25.45
Market Cap Chart
Since April 29, 2010, Allied Biotech's market cap has increased from 1.27B to 2.51B, an increase of 97.10%. That is a compound annual growth rate of 4.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 2.51B | 12.99% |
| Dec 31, 2025 | 2.22B | 33.44% |
| Dec 31, 2024 | 1.67B | 5.41% |
| Dec 29, 2023 | 1.58B | 17.93% |
| Dec 30, 2022 | 1.34B | -7.84% |
| Dec 30, 2021 | 1.45B | -9.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 263.50B |
| PharmaEssentia | 217.10B |
| Lotus Pharmaceutical | 84.02B |
| Heron Neutron Medical | 69.56B |
| Bora Pharmaceuticals Co., LTD. | 67.84B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 31.25B |
| Lin BioScience | 31.15B |